MATERNAL SERUM SCREEN 2 DUAL Test
The Maternal Serum Screen 2 Dual Test is a prenatal screening test offered by DNA Labs UAE. This test measures the levels of certain substances in a pregnant woman’s blood to assess the risk of certain birth defects and genetic conditions in the fetus.
Test Components
- PAPP-A
- Free Beta HCG
- Risk Evaluation
Test Cost
The cost of the MATERNAL SERUM SCREEN 2 DUAL Test is AED 500.0.
Sample Condition
For the test, a minimum of 3 mL (1.5 mL min.) serum from 1 SST is required. The sample should be shipped refrigerated or frozen. Additionally, the following information must be provided: maternal Date of birth (dd/mm/yy), LMP or Ultrasound, Number of Fetuses (Single/Twins), Diabetic status, Body Weight in Kg, IVF, Smoking, and Previous history of Trisomy 21 pregnancy. It is mandatory to fill the Maternal Serum Screen requisition form (Form 11). The test is valid between 9-13 weeks gestation, with an ideal time of 10-13 weeks.
Report Delivery
The sample should be provided from Monday through Saturday by 9 am. The report will be delivered on the same day.
Method
The MATERNAL SERUM SCREEN 2 DUAL Test is performed using the Chemiluminescent Immunoassay method.
Test Type
The test falls under the category of Prenatal Diagnosis.
Doctor
The test is recommended to be conducted under the supervision of a Gynecologist.
Test Department
The test is conducted in the THYROID & HORMONES department.
Pre Test Information
Prior to taking the test, the following information must be provided: maternal Date of birth (dd/mm/yy), LMP or Ultrasound, Number of Fetuses (Single/Twins), Diabetic status, Body Weight in Kg, IVF, Smoking, and Previous history of Trisomy 21 pregnancy. It is mandatory to fill the Maternal Serum Screen requisition form (Form 11). The test is valid between 9-13 weeks gestation, with an ideal time of 10-13 weeks.
Test Details
The Maternal Serum Screen 2 Dual Test is a prenatal screening test that measures the levels of alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) in the maternal blood. These substances are analyzed to assess the risk of neural tube defects (such as spina bifida) and chromosomal abnormalities (such as Down syndrome) in the fetus. The test is typically performed between 15 and 20 weeks of pregnancy.
The results of the Maternal Serum Screen 2 Dual Test are combined with other factors such as the mother’s age, gestational age, and ethnicity to calculate a risk score. This score helps healthcare providers determine if further diagnostic testing, such as amniocentesis or chorionic villus sampling, is necessary.
It is important to note that the Maternal Serum Screen 2 Dual Test is a screening test and not a diagnostic test. A positive result does not necessarily indicate that the fetus has a birth defect or genetic condition, but rather suggests an increased risk that further testing may be required. It is recommended to discuss the test with a healthcare provider to understand its benefits, limitations, and implications for the pregnancy.
| Test Name | MATERNAL SERUM SCREEN 2 DUAL Test Test |
|---|---|
| Components | *PAPP-A*Free Beta HCG*Risk Evaluation |
| Price | 500.0 AED |
| Sample Condition | 3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Provide maternal Date of birth (dd\/mm\/yy); LMP or Ultrasound; Number of Fetuses (Single\/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisitionform (Form 11) is mandatory. Valid between 9-13 weeks gestation (Ideal 10-13 weeks). |
| Report Delivery | Sample Mon through Sat by 9 am; Report Same day |
| Method | Chemiluminescent Immunoassay |
| Test type | Prenatal Diagnosis |
| Doctor | Gynecologist |
| Test Department: | THYROID & HORMONES |
| Pre Test Information | Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisitionform (Form 11) is mandatory. Valid between 9-13 weeks gestation (Ideal 10-13 weeks). |
| Test Details |
The Maternal Serum Screen 2 Dual Test is a prenatal screening test that measures the levels of certain substances in a pregnant woman’s blood to assess the risk of certain birth defects and genetic conditions in the fetus. This test is typically performed between 15 and 20 weeks of pregnancy. The test measures the levels of two substances in the maternal blood: alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG). Abnormal levels of these substances may indicate an increased risk of neural tube defects (such as spina bifida) or chromosomal abnormalities (such as Down syndrome) in the fetus. The results of the Maternal Serum Screen 2 Dual Test are combined with other factors such as the mother’s age, gestational age, and ethnicity to calculate a risk score. This score helps healthcare providers determine if further diagnostic testing, such as amniocentesis or chorionic villus sampling, is necessary. It’s important to note that the Maternal Serum Screen 2 Dual Test is a screening test, not a diagnostic test. A positive result does not necessarily mean that the fetus has a birth defect or genetic condition, but rather indicates an increased risk that further testing may be warranted. It’s recommended to discuss the test with a healthcare provider to understand its benefits, limitations, and implications for the pregnancy. |
